Editorial: Bile Acids Under Bulevirtide—A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-07 · 64 (2) · 261-262
DOI: 10.1111/apt.70742 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-05-25. Written by Marlene Hintersteininger and 2 co-authors. Institution: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. 10 references.
Abstract (original language)
Ebda abstract disponibbli.
Authors and institutions
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
ORCID profiles: Marlene Hintersteininger, Thomas Reiberger, Mathias Jachs
Cite
APA
Hintersteininger, M., Reiberger, T., & Jachs, M. (2026). Editorial: Bile Acids Under Bulevirtide—A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(2), 261-262. https://doi.org/10.1111/apt.70742
Vancouver
Hintersteininger M, Reiberger T, Jachs M. Editorial: Bile Acids Under Bulevirtide—A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(2):261-262. doi:10.1111/apt.70742
BibTeX
@article{Hintersteininger2026,
author = {Hintersteininger, Marlene and Reiberger, Thomas and Jachs, Mathias},
title = {Editorial: Bile Acids Under Bulevirtide—A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {2},
pages = {261--262},
doi = {10.1111/apt.70742}
}
EUVIMED